Joseph G. Pressey · Pediatric BRAF (V600E)-Mutated Pancreatic Acinar Cell Carcinoma With Complete and Durable Response to Dabrafenib and Trametinib
Follow
Article1 min read·Published Jan 2020Older

Pediatric BRAF (V600E)-Mutated Pancreatic Acinar Cell Carcinoma With Complete and Durable Response to Dabrafenib and Trametinib

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Jan 2020 · 1 min read

In brief

In brief

Case report of a pediatric patient with BRAF V600E-mutated pancreatic acinar cell carcinoma achieving complete and sustained response to combination dabrafenib and trametinib targeted therapy.

Written by the GCMD Library team from the article.

Joseph G. Pressey

JCO precision oncology · 2020

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →
GCMD Library — educational content from recorded physician discussions, not medical advice.